Device and method for the delivery of drugs for the treatment of posterior segment disease
US9216106B2 · kind B2 · utility
2Cited by
72References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 2, 2008 |
| Grant date | Dec 22, 2015 |
| Priority date | — |
| Expiry date | May 15, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Hydrogel lenses are infused with a drug for the treatment of posterior segment disease. The lenses are placed in contact with the subject's cornea. Drugs can be passively released from the hydrogel and can migrate around the globe of the eye to the posterior segment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.